Daily Stock Analysis, BEAT, BioTelemetry Inc, priceseries

BioTelemetry Inc. Daily Stock Analysis
Stock Information
Open
59.48
Close
58.73
High
60.00
Low
57.58
Previous Close
58.57
Daily Price Gain
0.16
YTD High
80.92
YTD High Date
Feb 5, 2019
YTD Low
52.80
YTD Low Date
Apr 18, 2019
YTD Price Change
-0.61
YTD Gain
-1.03%
52 Week High
80.92
52 Week High Date
Feb 5, 2019
52 Week Low
32.65
52 Week Low Date
Apr 25, 2018
52 Week Price Change
24.98
52 Week Gain
74.01%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 31. 2017
23.05
Feb 28. 2017
25.50
19 Trading Days
10.64%
Link
LONG
Jun 26. 2017
30.55
Jul 11. 2017
32.09
10 Trading Days
5.05%
Link
LONG
Dec 11. 2017
27.75
Dec 29. 2017
30.31
13 Trading Days
9.21%
Link
LONG
Jan 11. 2018
31.60
Jan 31. 2018
33.92
13 Trading Days
7.33%
Link
LONG
Apr 9. 2018
31.75
Apr 23. 2018
33.80
10 Trading Days
6.45%
Link
LONG
Oct 31. 2018
58.10
Nov 12. 2018
62.28
8 Trading Days
7.20%
Link
LONG
Jan 7. 2019
60.37
Feb 11. 2019
72.64
24 Trading Days
20.32%
Link
Company Information
Stock Symbol
BEAT
Exchange
NasdaqGS
Company URL
http://www.biotelinc.com
Company Phone
610-729-7000
CEO
Joe Capper
Headquarters
Pennsylvania
Business Address
227 WASHINGTON STREET #210, CONSHOHOCKEN, PA 19428
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0001574774
About

BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized core laboratory services for clinical research. The company also develops proprietary integrated patient management platform that incorporates wireless data transmission network. It operates through operates through three segments: Healthcare, Technology, and Research. The Healthcare segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Technology segment engages in the development, manufacturing, testing, and marketing of medical devices to medical companies, clinics, and hospitals. The Research segment engages in the central core laboratory services that provides cardiac monitoring, scientific consulting, and data management services for drug and medical device trials. The company was founded on April 22, 2013 and is headquartered in Malvern, PA.

Description

BioTelemetry, Inc. provides cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. The company operates in three segments: Healthcare, Research, and Technology. The Healthcare segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. It offers Mobile Cardiac Outpatient Telemetry and External Cardiac Ambulatory Telemetry services, which incorporates a lightweight patient-worn sensor attached to electrodes that capture two-channel electrocardiography (ECG) data, measuring electrical activity of the heart, on a compact wireless handheld monitor; event monitoring services to prescribe wireless event monitors, digital loop event monitors, memory loop event monitors, and non-loop event monitors; and a Holter and extended-wear Holter monitors to cardiologists and electrophysiologists. The Research Services segment provides cardiac monitoring, imaging, scientific consulting, and data management services for drug, medical treatment, and device trials to pharmaceutical companies and contract research organizations. Its centralized services include ECG, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, and expert reporting and statistical analysis. This segment also offers services in the cardiovascular, oncology, musculoskeletal, and neurologic therapeutic areas; and support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The Technology segment focuses on the manufacture, engineering, and development of non-invasive cardiac monitors for healthcare companies, clinics, and hospitals worldwide. This segment offers various devices, including cardiac event monitors, digital Holter monitors, and mobile cardiac telemetry monitors. BioTelemetry, Inc. is headquartered in Malvern, Pennsylvania.